Updated on 17.12.2025 @ 10:55 AM
Park Medi World Limited, a prominent hospital chain in North India, is set to launch its mainboard Initial Public Offering (IPO) on December 10, 2025. If you're interested for more IPOs details, you can also access our IPO calendar for latest, upcoming and live IPOs.
The subscription for this public issue will close on December 12, 2025.
The company aims to raise up to ₹920 crores through a mix of a fresh issue and a small Offer for Sale (OFS).
The price band has been fixed at ₹154 to ₹162 per share, with a minimum lot size of 92 shares.
Park Medi World has demonstrated strong revenue growth and a successful inorganic expansion strategy, but investors should be mindful of its debt levels and the performance of its subsidiaries.
For readers who want to strengthen their understanding of mutual funds and sensible long-term investing, our mutual fund learning platform can help you build the right foundation. You can also use our SIP calculator to estimate returns and plan investments more accurately.
In this article, you will find Park Medi World IPO GMP today, subscription status, allotment date, price band, and a detailed, unbiased review to help you make an informed decision.
Briefs of Park Medi World IPO Details
- Price Band: ₹154 – ₹162 per share
- IPO Open / Close Dates: December 10, 2025 – December 12, 2025
- Lot Size: 92 Shares
- Issue Size: ₹920 Crores (Fresh Issue of ₹770 Cr + OFS of ₹150 Cr)
- Fresh Issue / OFS: Both
- Registrar: Kfin Technologies Ltd.
- Listing Exchange: BSE & NSE
What is The Park Medi World IPO GMP Today?
Check the grey market premium of this and other IPOs at a single place. Grey market premium hub page.
Listing Updates.
| Type | Issue Price | Open | Gain/loss |
| Lisiting | 162 | 158.8 | -2.0 |
What Are The Park Medi World IPO Dates & Allotment Schedule?
- IPO Open & Close Date: December 10, 2025 – December 12, 2025
- Basis of Allotment Date: December 15, 2025
- Refund Initiation Date: December 16, 2025
- Credit of Shares: December 16, 2025
- Listing Date: December 17, 2025
What Are The Objectives of Park Medi World IPO?
The company intends to utilise the net proceeds from the fresh issue for debt reduction and expansion:
- Repayment of Borrowings (₹380.00 Crores): A significant portion of the proceeds will be used to repay outstanding debt, which will reduce finance costs and improve the leverage ratio.
- Capital Expenditure(60.5 Crores): Funding the development of a new hospital by its subsidiary, Park Medicity (NCR), and purchasing medical equipment to upgrade facilities.
- Funding Capital Expenditure for Medical Equipment Purchase (27.4 Crores): Funding capital expenditure for purchase of medical equipment by our Company and our Subsidiaries, Blue Heavens and Ratangiri.
- General Corporate Purposes: The balance amount will be used for other strategic requirements.
How is the Financial Performance of Park Medi World?
The following table summarizes the company's financial performance based on restated consolidated data.
(Amounts in ₹ Crores)
| Particulars | Period Ended 30 Sep 2025 | Year Ended 31 Mar 2025 | Year Ended 31 Mar 2024 | Year Ended 31 Mar 2023 |
Total Income | 823.39 | 1,425.97 | 1,263.08 | 1,272.18 |
Profit After Tax (PAT) | 139.14 | 213.22 | 152.01 | 228.19 |
EBITDA | 217.1 | 372.17 | 310.30 | 390.3 |
Total Borrowing | 733.91 | 682.07 | 686.71 | 575.68 |
Assets | 2,320.93 | 2,133.70 | 1,912.10 | 1,592.82 |
Source: RHP
Key Financial Observations:
Profit After Tax (PAT):
The company's PAT rebounded strongly to ₹213.22 Crores in FY25 after a dip in FY24 due to subsidiary losses. The momentum continues with ₹139.14 Crores profit in the first half of FY26, showcasing improved operational efficiency.
Total Income:
Revenue has grown consistently, driven by organic expansion and strategic acquisitions. The company leverages its strong regional presence in North India to capture market share.
EBITDA:
Operational profitability is robust, with EBITDA margins reaching around 26.7% in FY25. This indicates efficient management of hospital operations and cost structures.
Total Borrowings:
The company carries a significant debt load of ₹733.91 Crores as of September 2025. The IPO proceeds allocated for repayment will help deleverage the balance sheet and reduce interest burden.
Assets:
Total assets have expanded steadily to ₹2,320.93 Crores, reflecting continuous investment in hospital infrastructure and medical equipment to support growth.
P/E Ratio & Peer Comparison
Based on its Fiscal Year 2025 earnings per share (EPS) of ₹5.55, the IPO is priced at a Price-to-Earnings (P/E) multiple of approximately 29.2x at the upper end of the price band (₹162).
P/E Ratio = ₹162 (Price) / ₹5.55(Earnings Per Share)
P/E Ratio ≈ 29.2x
This valuation appears highly attractive when compared to its listed industry peers.
| Company Name | P/E Ratio | Revenue (FY25, ₹ Cr) | RoNW (%) (FY25) |
Park Medi World (at IPO price) | ~29.2x | 1,425.97 | 20.08% |
| Apollo Hospitals | 73.43x | 21,994.30 | 17.63% |
| Fortis Healthcare | 90.42x | 7,849.70 | 8.69% |
| Narayana Hrudayalaya | 50.10x | 5,575.00 | 21.80% |
| Max Healthcare | 101.54x | 7,184.10 | 11.47% |
Analysis for Investors:
Park Medi World is being offered at a substantial discount to the industry average P/E of nearly 69x. With a P/E of just ~29x, it is significantly cheaper than peers like Max Healthcare and Apollo Hospitals.
Furthermore, its Return on Net Worth (RoNW) of over 20% is superior to most competitors, indicating efficient capital utilization. This combination of low valuation and high efficiency makes the IPO pricing look very compelling.
Industry Outlook
- The Indian healthcare delivery market is poised for robust growth, driven by an aging population, rising income levels, and increasing insurance penetration.
- North India, Park Medi World's stronghold, is expected to be the fastest-growing region for healthcare services.
- The demand for quality tertiary and quaternary care is outstripping supply, creating opportunities for established hospital chains to expand.
What Are the Strengths and Risks of Park Medi World IPO?
Strengths:
- Regional Leadership: Strong market position as a leading hospital chain in North India and Haryana.
- Proven Acquisition Strategy: Successful track record of acquiring and integrating hospitals to drive growth.
- Robust Financials: Consistent revenue growth and improving profitability margins.
- Attractive Valuation: Priced significantly lower than industry peers, offering a margin of safety.
Risks:
- Subsidiary Performance: Some subsidiaries have reported losses in the past, which could impact consolidated results.
- High Debt: Current debt levels are significant, though the IPO aims to reduce this.
- Regulatory Risks: The healthcare sector is subject to stringent regulations and price controls.
- Litigation: The company is involved in various legal proceedings which could pose a financial risk.
What Are The Expert Recommendations – Should You Apply?
Read the RHP Carefully before investing or hire an IFA. This should not be treated as advice.
The Park Medi World IPO presents a compelling opportunity to invest in a growing hospital chain at a bargain valuation.
- For Value Investors: The P/E of ~29.2x is a massive discount to the sector average, making it a highly attractive value pick.
- For Growth Investors: The company's expansion plans and strong regional footprint offer significant growth potential.
- Our View: Despite the debt and subsidiary risks, the company's strong fundamentals and very attractive pricing make it a strong candidate. We recommend "Subscribe" for potential listing gains and long-term holding.
Key Takeaways
- IPO Price Band: ₹154 to ₹162 per share
- Lot Size: 92 Shares (Minimum Investment: ₹14,904)
- GMP Today: ₹0 (Not trading)
- Allotment & Listing Dates: Tentative listing on December 17, 2025.
- Recommendations of experts: A "Subscribe" recommendation. A financially robust hospital chain offered at a significant valuation discount to its peers.
FAQs on Park Medi World IPO
What is Park Medi World IPO price band?
The price band for the IPO is set at ₹154 to ₹162 per equity share.
What is Park Medi World IPO allotment date?
The allotment of shares is tentatively expected to be finalized on Monday, December 15, 2025.
How to check Park Medi World IPO allotment status?
You can check the allotment status on the website of the IPO registrar once the basis of allotment is finalized.
What is Park Medi World IPO listing date?
The company's shares are tentatively scheduled to be listed on the BSE and NSE on Wednesday, December 17, 2025.
Should I apply for Park Medi World IPO?
Yes, this is a recommended IPO. The company has demonstrated strong financial performance and is offered at a valuation significantly lower than its listed peers, making it an attractive investment opportunity.
Disclaimer:
This IPO information is for educational purposes only and is not investment advice. Please review the official RHP and consult a SEBI-registered advisor before investing. Market investments carry risks.
